| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2019 ( Subtotal = -$323,523 ) |
| | 2019 | 2017 | IMPEL NEUROPHARMA, INC. | 201 ELLIOTT AVE W #260 | SEATTLE | WA | 98122-4265 | KING | USA | R44MH099720 | Tool for non-invasive delivery of central nervous system drug candidates | 000 | 4 | NIH | 11/5/2018 | -$323,523 |
|
| Issue Date FY: 2018 ( Subtotal = $0 ) |
| | 2018 | 2017 | IMPEL NEUROPHARMA, INC. | 201 ELLIOTT AVE W #260 | SEATTLE | WA | 98122-4265 | KING | USA | R44MH099720 | Tool for non-invasive delivery of central nervous system drug candidates | 000 | 4 | NIH | 9/22/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $574,487 ) |
| | 2017 | 2017 | IMPEL NEUROPHARMA, INC. | 915 E PINE ST | SEATTLE | WA | 98122-3849 | KING | USA | R44MH099720 | Tool for non-invasive delivery of central nervous system drug candidates | 000 | 4 | NIH | 7/28/2017 | $574,487 |
|
| Issue Date FY: 2016 ( Subtotal = $914,222 ) |
| | 2016 | 2016 | IMPEL NEUROPHARMA INC | 867 SOUTHWEST SHOREMONT AVENUE | NORMANDY PARK | WA | 98166 | KING | USA | R44MH099720 | Tool for non-invasive delivery of central nervous system drug candidates | 000 | 3 | NIH | 3/29/2016 | $914,222 |
|
| Issue Date FY: 2014 ( Subtotal = $328,793 ) |
| | 2014 | 2014 | IMPEL NEUROPHARMA INC | 867 SOUTHWEST SHOREMONT AVENUE | NORMANDY PARK | WA | 98166 | KING | USA | R43MH099720 | Tool for non-invasive delivery of central nervous system drug candidates | 000 | 2 | NIH | 11/14/2013 | $328,793 |
|
| Issue Date FY: 2013 ( Subtotal = $346,264 ) |
| | 2013 | 2013 | IMPEL NEUROPHARMA INC | 867 SOUTHWEST SHOREMONT AVENUE | NORMANDY PARK | WA | 98166 | KING | USA | R43MH099720 | Tool for non-invasive delivery of central nervous system drug candidates | 000 | 1 | NIH | 11/20/2012 | $346,264 |
|
| Issue Date FY: 2012 ( Subtotal = $149,513 ) |
| | 2012 | 2012 | IMPEL NEUROPHARMA INC | 867 SOUTHWEST SHOREMONT AVENUE | NORMANDY PARK | WA | 98166 | KING | USA | R43DA033096 | CENTRAL NERVOUS SYSTEM DELIVERY OF OPIOID PEPTIDES | 000 | 1 | NIH | 2/13/2012 | $149,513 |
|
| Issue Date FY: 2010 ( Subtotal = $245,889 ) |
| | 2010 | 2010 | IMPEL NEUROPHARMA INC | 867 SOUTHWEST SHOREMONT AVENUE | NORMANDY PARK | WA | 98166 | KING | USA | R43MH086351 | CNS TARGETED DELIVERY OF ANTI-HIV DRUGS | 001 | 2 | NIH | 6/11/2010 | $245,889 |
| | 2010 | 2009 | IMPEL NEUROPHARMA INC | 867 SOUTHWEST SHOREMONT AVENUE | NORMANDY PARK | WA | 98166 | KING | USA | R43MH086351 | CNS TARGETED DELIVERY OF ANTI-HIV DRUGS | 000 | 1 | NIH | 2/12/2010 | $0 |
|
| Issue Date FY: 2009 ( Subtotal = $249,356 ) |
| | 2009 | 2009 | IMPEL NEUROPHARMA INC | 867 SOUTHWEST SHOREMONT AVENUE | NORMANDY PARK | WA | 98166 | KING | USA | R43MH086351 | CNS TARGETED DELIVERY OF ANTI-HIV DRUGS | 000 | 1 | NIH | 6/10/2009 | $249,356 |
|
|
